ABOUT THIS STUDY
- Breast cancer with evidence of unresectable, locally recurrent, or metastatic disease.
- Tumors over-expressing Her-2
- Candidate for treatment with docetaxel/trastuzumab
- Histology of inflammatory carcinoma
- AST and/or ALT >1.5 x ULN concomitant with ALP >2.5 x ULN
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Washington, District of Columbia
- Baltimore, Maryland
- Badalona, Barcelona